Anne L. Holleran

Array ( [id] => 10580962 [patent_doc_number] => 09303081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Recombinant production of mixtures of antibodies' [patent_app_type] => utility [patent_app_number] => 12/932719 [patent_app_country] => US [patent_app_date] => 2011-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 33969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12932719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6087887 [patent_doc_number] => 20110217297 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-08 [patent_title] => 'METHODS FOR CLASSIFYING AND TREATING BREAST CANCERS' [patent_app_type] => utility [patent_app_number] => 13/040042 [patent_app_country] => US [patent_app_date] => 2011-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 41006 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20110217297.pdf [firstpage_image] =>[orig_patent_app_number] => 13040042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408957 [patent_doc_number] => 09556249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Neuregulin antagonists and use thereof in treating cancer' [patent_app_type] => utility [patent_app_number] => 13/029199 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 19 [patent_no_of_words] => 29580 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13029199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12044576 [patent_doc_number] => 09822169 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-11-21 [patent_title] => 'Compositions and methods of use for determination of HE4a' [patent_app_type] => utility [patent_app_number] => 13/985983 [patent_app_country] => US [patent_app_date] => 2011-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 19297 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13985983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8239853 [patent_doc_number] => 20120148589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'HUMAN CANCER-RELATED GENE, ITS ENCODED PRODUCTS AND APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/019297 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9169 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13019297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9389070 [patent_doc_number] => 08685666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-01 [patent_title] => 'ARL-1 specific antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/017618 [patent_app_country] => US [patent_app_date] => 2011-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 29893 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 160 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13017618 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7766172 [patent_doc_number] => 20120034227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'MONOCLONAL ANTIBODY THERAPY FOR PANCREAS CANCER' [patent_app_type] => utility [patent_app_number] => 13/011485 [patent_app_country] => US [patent_app_date] => 2011-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7724 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034227.pdf [firstpage_image] =>[orig_patent_app_number] => 13011485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5958505 [patent_doc_number] => 20110182892 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'Methods to identify responsive patients' [patent_app_type] => utility [patent_app_number] => 13/008452 [patent_app_country] => US [patent_app_date] => 2011-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12454 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20110182892.pdf [firstpage_image] =>[orig_patent_app_number] => 13008452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5938000 [patent_doc_number] => 20110213128 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'SIRNA CAPABLE OF INHIBITING THE EXPRESSION OF AN ONCOGENE INVOLVED IN CERVICAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/005198 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22677 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20110213128.pdf [firstpage_image] =>[orig_patent_app_number] => 13005198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054569 [patent_doc_number] => 20110110929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'HUMAN ANTI-IDIOTYPIC ANTIBODY FRAGMENTS THAT MIMIC HER-2/NEU' [patent_app_type] => utility [patent_app_number] => 13/005300 [patent_app_country] => US [patent_app_date] => 2011-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11513 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20110110929.pdf [firstpage_image] =>[orig_patent_app_number] => 13005300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174238 [patent_doc_number] => 20110177062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'METHODS FOR TREATING BREAST CANCER' [patent_app_type] => utility [patent_app_number] => 12/984509 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 27546 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177062.pdf [firstpage_image] =>[orig_patent_app_number] => 12984509 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10187621 [patent_doc_number] => 09217032 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-22 [patent_title] => 'Methods for treating colorectal cancer' [patent_app_type] => utility [patent_app_number] => 12/984532 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 72 [patent_no_of_words] => 32403 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12984532 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375527 [patent_doc_number] => 08679790 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Leader sequence to boost gene expression' [patent_app_type] => utility [patent_app_number] => 12/984251 [patent_app_country] => US [patent_app_date] => 2011-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 20192 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12984251 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6101669 [patent_doc_number] => 20110165161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'ANTI-EPCAM ANTIBODIES THAT INDUCE APOPTOSIS OF CANCER CELLS AND METHODS USING SAME' [patent_app_type] => utility [patent_app_number] => 12/977976 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 31953 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20110165161.pdf [firstpage_image] =>[orig_patent_app_number] => 12977976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10103884 [patent_doc_number] => 09139658 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-22 [patent_title] => 'Medicament for treatment cancer' [patent_app_type] => utility [patent_app_number] => 12/978275 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5181 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12978275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6038846 [patent_doc_number] => 20110091895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Immunoassays to Detect Diseases or Disease Susceptibility Traits' [patent_app_type] => utility [patent_app_number] => 12/975270 [patent_app_country] => US [patent_app_date] => 2010-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19216 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091895.pdf [firstpage_image] =>[orig_patent_app_number] => 12975270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164121 [patent_doc_number] => 08173424 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Internalizing ErbB2 antibodies' [patent_app_type] => utility [patent_app_number] => 12/928792 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28756 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173424.pdf [firstpage_image] =>[orig_patent_app_number] => 12928792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6142168 [patent_doc_number] => 20110129464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'HUMANIZED ANTI-ERBB2 ANTIBODIES AND TREATMENT WITH ANTI-ERBB2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/970711 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36376 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20110129464.pdf [firstpage_image] =>[orig_patent_app_number] => 12970711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9503275 [patent_doc_number] => 08741586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-03 [patent_title] => 'Antibodies against HER2 truncated variant CTF-611' [patent_app_type] => utility [patent_app_number] => 12/961004 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10990 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12961004 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000694 [patent_doc_number] => 20110117096 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies' [patent_app_type] => utility [patent_app_number] => 12/955727 [patent_app_country] => US [patent_app_date] => 2010-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 37030 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117096.pdf [firstpage_image] =>[orig_patent_app_number] => 12955727 [rel_patent_id] =>[rel_patent_doc_number] =>)